Tag: Fenestrated Treo
Terumo Aortic announces US FDA Breakthrough Device designation for Fenestrated Treo
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation for the Fenestrated Treo abdominal stent-graft system, Terumo Aortic announced today.
The FDA’s...
Terumo Aortic announces launch of Fenestrated Treo pivotal IDE study in...
Terumo Aortic today announced enrolment of the first patient in the Fenestrated Treo pivotal investigational device exemption (IDE) study in the USA. This study...
Terumo Aortic and Bentley announce collaboration on US FEVAR study
Terumo Aortic and Bentley today announced their partnership in a clinical study in the USA. The objective is to obtain US Food and Drug...
Terumo Aortic announces the first commercial implant of Fenestrated TREO in...
This advertorial is sponsored by Terumo Aortic.
On 9 April 2024, a significant milestone was achieved as Terumo Aortic introduced the first implantation of the...
